Amgen

positive negative up down good bad mixed
Biotech

Amgen's ph. 3 MariTide study will ramp up dosing to quell nausea

The company noted high rates of discontinuation due to gastrointestinal events, such as vomiting, in fixed-dose arms of its phase 2 trial.
Zoey Becker Jun 24, 2025 9:59am
finch canary cage free bird release

FDA lifts hold on Amgen's phase 1 obesity study

May 2, 2025 10:10am
Abstract modern white spiral clock dial with roman and arabic numerals

Lilly links lepodisiran to durably lower lipoprotein in phase 2

Mar 31, 2025 4:24am
rocket launch satellite space fly blast off

Amgen ignites Rocket program with wins in phase 3 eczema trials

Mar 10, 2025 5:48am
chop down cut tree chainsaw ax

Amgen, CytomX ax T-cell engager after assessing data, priorities

Mar 7, 2025 5:39am
boat cutting through water

Amgen’s late-stage obesity trials expected to read out in ‘27

Mar 5, 2025 1:58pm